{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:54:02Z","timestamp":1747180442110,"version":"3.40.5"},"reference-count":32,"publisher":"Informa UK Limited","issue":"2-3","funder":[{"name":"NIH\/NIMH","award":["R01 MH105857"],"award-info":[{"award-number":["R01 MH105857"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Research & Clinical Practice"],"published-print":{"date-parts":[[2020,5,3]]},"DOI":"10.1080\/25787489.2020.1798083","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T08:59:30Z","timestamp":1595494770000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Trial designs for evaluating combination HIV prevention approaches"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-3391","authenticated-orcid":false,"given":"Ying Qing","family":"Chen","sequence":"first","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Peng","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Appelmans","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-7247","authenticated-orcid":false,"given":"Sayan","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14341-3"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)80008-7"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.01.004"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511691"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu815"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051537"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506110"},{"key":"e_1_3_2_17_1","unstructured":"HPTN. HPTN 083: a phase 2b\/3 double blind safety and efficacy study of injectable cabotegravir compared to daily oral Tenofovir Disoproxil Fumarate\/Emtricitabine (TDF\/FTC) for pre-exposure prophylaxis in HIV-uninfected cisgender men and transgender women who have sex with men. https:\/\/www.hptn.org\/research\/studies\/hptn083#block-views-block-study-related-publications-block-1. Published July 20 2020. Accessed November 1 2018."},{"key":"e_1_3_2_18_1","unstructured":"HPTN. HPTN 084: a phase 3 double blind safety and efficacy study of long-acting injectable cabotegravir compared to daily oral TDF\/FTC for pre-exposure prophylaxis in HIV-uninfected women. https:\/\/www.hptn.org\/research\/studies\/hptn083#block-views-block-study-related-publications-block-1. Published July 20 2020. Accessed November 1 2018."},{"key":"e_1_3_2_19_1","unstructured":"HVTN. uhambo(HVTN 702): a pivotal phase 2b\/3 multi-site randomized double-blind placebo-controlled clinical trial to evaluate the safety and efficacy of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120\/MF59 in preventing HIV-1 infection in adults in South Africa. http:\/\/uhambo.org.za\/. Published July 20 2020. Accessed December 2 2018."},{"key":"e_1_3_2_20_1","unstructured":"HPTN Ha. AMP(HVTN 703\/HPTN 081): a phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa. https:\/\/ampstudy.org.za\/about. Published July 20 2020. Accessed December 2 2018."},{"key":"e_1_3_2_21_1","unstructured":"HPTN Ha. AMP(HVTN 704\/HPTN 085): a phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection among men and transgender persons who have sex with men. https:\/\/ampstudy.org\/. Published July 20 2020. Accessed December 2 2018."},{"key":"e_1_3_2_22_1","unstructured":"HVTN. IMBOKODO (HVTN 705\/HPX2008): a multicenter randomized double-blind placebo-controlled phase 2b efficacy study of a heterologous prime\/boost vaccine regimen of Ad26.Mos4.HIV and aluminum phosphateadjuvanted Clade C gp140 in preventing HIV-1 infection in adult women. https:\/\/www.imbokodo.org.za\/. Published July 20 2020. Accessed December 2 2018."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16588-4"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318299eff0"},{"key":"e_1_3_2_25_1","unstructured":"UNAIDS Report on the Global AIDS Epidemic Geneva; 2010."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-57"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197904"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00078-0"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61898-4"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111090-00013"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000223283.27142.9f"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013801"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001435"}],"container-title":["HIV Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/25787489.2020.1798083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:59:41Z","timestamp":1717599581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/25787489.2020.1798083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,3]]},"references-count":32,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2020,5,3]]}},"alternative-id":["10.1080\/25787489.2020.1798083"],"URL":"https:\/\/doi.org\/10.1080\/25787489.2020.1798083","relation":{},"ISSN":["2578-7489","2578-7470"],"issn-type":[{"type":"print","value":"2578-7489"},{"type":"electronic","value":"2578-7470"}],"subject":[],"published":{"date-parts":[[2020,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-01-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}